Cortexyme shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Cortexyme (QNCX) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Cortexyme
Tip: Access up to 7 years of quarterly data
All positions including Cortexyme held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cortexyme by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $491 | 469 | 1.05 |
| 2023-09-30 | $524 | 469 | 1.12 |
| 2023-06-30 | $705 | 469 | 1.51 |
| 2023-03-31 | $1.0k | 469 | 2.13 |
| 2022-12-31 | $0 | 469 | 0.00 |
| 2022-06-30 | $1.3M | 567k | 2.28 |
| 2022-03-31 | $3.7M | 590k | 6.20 |
| 2021-12-31 | $140k | 10k | 13.89 |
| 2021-03-31 | $321k | 8.9k | 36.11 |
| 2020-12-31 | $457k | 17k | 26.55 |
| 2020-09-30 | $539k | 11k | 50.32 |
| 2020-06-30 | $481k | 10k | 46.34 |
| 2020-03-31 | $655k | 14k | 45.66 |
| 2019-12-31 | $673k | 12k | 56.08 |
| 2019-09-30 | $83k | 3.3k | 25.13 |
| 2019-06-30 | $78k | 1.9k | 39.97 |